Is your commercial field force truly operating at full capacity? Even when a team boasts 100% headcount, the reality is that true productivity rarely matches that number.
Organizations are quietly forfeiting revenue, not just to market competitors, but to the continuous cycle of vacant territories, extended leaves, and field force disengagement. Are you treating field turnover as an emergency, or managing it as a predictable operational variable?
When a territory goes dark, the impact is immediate and costly. The 90 days it typically takes to backfill a role can completely derail promotional cadence and weaken critical healthcare provider (HCP) relationships.
In highly specialized markets like rare disease, where every single interaction carries immense weight, these gaps in coverage lead to significant revenue leakage and disrupt the continuity of patient support.
In this exclusive article, EVERSANA’s SVP of Business Development, Pete Riojas, Nassi Agouridis, Head of Sales, Rare Disease at UCB, and Frank Amato, CIMA Sciences CEO, break down the hidden costs of field instability.
Discover how proactive commercial leaders are utilizing rapid virtual deployment and flexible vacancy management to protect their revenue, seamlessly maintain territory coverage, and safeguard their most valuable market relationships.
Download the full case study article
Author
Pete Riojas, Senior Vice President at EVERSANA, is a seasoned life sciences leader with more than three decades of experience guiding large, mid‑size, and emerging biopharma companies through complex commercialization challenges. His career spans…